Andrea Sardella PhD Stevanato Group
Andrea Sardella PhD Stevanato Group Product Development Manager
Andrea holds a degree in Physics from Padua University and a Master's in Nuclear Engineering.
As a researcher at the National Research Council (C.N.R.), he developed several optoelectronic and nuclear scientific instruments for Magnetically Controlled Fusion Research. He also set up international collaborations with UWA Madison (USA) and Garching IPP (DE).
After ten years of activity in research, he moved to the industrial sector to develop optical and vision controls for industrial applications as CEO of a small-medium company. This experience drove him into the pharmaceutical field, where he started to develop several control applications with vision and spectroscopy tools.
He then joined a leading company as R&D Manager, for which he developed an innovative inspection technology for inspection machines.
Since 2008 he has been with Stevanato Group first as Pharma Inspection Product Development Manager. Here, he works to develop new automation and inspection products dedicated to the pharmaceutical customers of the Group.
As a researcher at the National Research Council (C.N.R.), he developed several optoelectronic and nuclear scientific instruments for Magnetically Controlled Fusion Research. He also set up international collaborations with UWA Madison (USA) and Garching IPP (DE).
After ten years of activity in research, he moved to the industrial sector to develop optical and vision controls for industrial applications as CEO of a small-medium company. This experience drove him into the pharmaceutical field, where he started to develop several control applications with vision and spectroscopy tools.
He then joined a leading company as R&D Manager, for which he developed an innovative inspection technology for inspection machines.
Since 2008 he has been with Stevanato Group first as Pharma Inspection Product Development Manager. Here, he works to develop new automation and inspection products dedicated to the pharmaceutical customers of the Group.